




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardio-Oncology</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=a111dd2d-31c2-4097-b779-01457a536a5e</link>
        <description>Clinical Topic Feed: Cardio-Oncology</description>
        <language>en</language>

        

                <item>
                    <title>ACC Featured Jobs For May 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1777629480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Management of Checkpoint Inhibitor Myocarditis in the CCU</title>
<link>/Latest-in-Cardiology/Articles/2026/03/12/10/54/Management-of-Checkpoint-Inhibitor-Myocarditis-in-the-CCU</link>                    <description>A 75-year-old man with a history of remote anterior ST-segment elevation myocardial infarction and stage IV malignant melanoma treated with combination immunotherapy (ipilimumab/nivolumab) presented to the oncology clinic with 3 days of exertional dyspnea and 24 hours of diplopia and neck weakness.</description>
                    <pubdate>1773320700000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>The Role of Exercise in Cardio-Oncology</title>
<link>/Latest-in-Cardiology/Articles/2026/01/23/18/21/The-Role-of-Exercise-in-Cardio-Oncology</link>                    <description>As cancer survival rates improve due to advances in treatment, new challenges have emerged; one of the most serious is cancer therapy&#226;€“related cardiac dysfunction (CTRCD) and subsequent cardiovascular disease (CVD) among survivors of cancer.</description>
                    <pubdate>1769429520000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Top 2025 ACC Content</title>
<link>/Latest-in-Cardiology/Articles/2026/01/06/18/47/eagles-eye-view-07jan2025</link>                    <description>In this episode, Dr. Eagle looks back at 2025 and explores some of the significant developments that show how the College is responding to changes in the way we evaluate, manage, and follow patients with various types of cardiovascular disorders.</description>
                    <pubdate>1767798000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Top ACC Content in 2025</title>
<link>/Latest-in-Cardiology/Articles/2025/12/19/18/18/Top-ACC-Content-in-2025</link>                    <description>The most popular ACC.org content items of 2025.</description>
                    <pubdate>1766455200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Weight Reversal Post Tirzepatide Withdrawal </title>
<link>/Latest-in-Cardiology/Articles/2025/12/17/14/32/eagles-eye-view-17dec2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks&#226;€&#175;at the DANISH trial extended follow-up, evaluating which patients benefit most from primary prevention implantable cardioverter defibrillator (ICD) implantation.</description>
                    <pubdate>1765982040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Issues Guidance For Managing CV Risks Associated With Cancer Treatments</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/12/10/15/38/ACC-Issues-Guidance-For-Managing-CV-Risks-Associated-With-Cancer-Treatments</link>                    <description>With modern cancer therapeutics changing the landscape of cancer treatment, the need to address cardiovascular treatment-related complications is increasingly important.</description>
                    <pubdate>1765381740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Secondary Cardiovascular Prevention For Survivors of Childhood Cancer</title>
<link>/Latest-in-Cardiology/Articles/2025/11/10/15/28/Secondary-Cardiovascular-Prevention-For-Survivors-of-Childhood-Cancer</link>                    <description>Approximately half a million people in the United States are survivors of cancer diagnosed in childhood or adolescence. Over 50% of pediatric cancer patients have been treated with curative, but cardiotoxic, anthracycline-based therapies.</description>
                    <pubdate>1762798560000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Radiation-Induced Carotid Artery Stenosis and Afferent Baroreflex Failure</title>
<link>/Latest-in-Cardiology/Articles/2025/08/18/12/52/Radiation-Induced-Carotid-Artery-Stenosis-and-Afferent-Baroreflex-Failure</link>                    <description>Radiation therapy (RT) is a cornerstone in the treatment of head and neck cancer (HNC), used in up to 75% of patients. Because most patients require irradiation of the cervical lymph nodes adjacent to the carotid arteries, sparing these vessels from the radiation field is often not feasible.</description>
                    <pubdate>1755534960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CVD Risk Scores, CV Health Metrics Predict Greater Cancer Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/07/22/13/33/CVD-Risk-Scores</link>                    <description>Worse cardiovascular disease risk scores or cardiovascular  health metrics predict greater cancer risk, despite heterogeneity in cardiovascular disease risk metrics and cancer types, according to a study published July 15 in JACC: CardioOncology.</description>
                    <pubdate>1753204260000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>